Ocugen Inc. (NASDAQ: OCGN) announced leadership changes in its medical department. Huma Qamar, M.D., MPH, CMI, separated from the company as Chief Medical Officer effective May 8, 2026.

The company appointed Mohamed Genead, M.D., M.Sc., as Acting/Interim Chief Medical Officer on the same date, according to the company's filing.